ARCHIVES

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

This article is from The Cancer Letter archive.

Vol. 24 No. 03 | January 23, 1998

Download PDF Visit The Full Archive

Related Articles

Adding Aresenic To Therapy Improves APL Survival

July 27, 2007

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

Breast Cancer Treatment Studies Need Standard Definitions – Carbone

May 10, 1974

Clinical Trials Approved Last Month By NCI’s CTEP

May 31, 2002

Breast Asymmetry Predicts Breast Cancer, Study Finds

March 31, 2006

Program Announcement listed.

July 25, 2003